DC Chemicals

All products / DC9350

Faropenem daloxate
CAT. NO. DC9350

Faropenem daloxate

Pack sizes and prices

Pack sizePrice
100 mg$300 USDRequest a quote →
250 mg$600 USDRequest a quote →
1 g$1,200 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics. Faropenem daloxate is useful for penem and antibiotics. Faropenem medoxomil has excellent in vitro activity against Streptococcus pneumoniae, Haemophilus influenzae and other key pathogens implicated in acute bacterial rhinosinusitis. Clinical studies have demonstrated that, in the treatment of acute bacterial rhinosinusitis in adults, 7 days of treatment with faropenem medoxomil is as clinically and bacteriologically effective as 10 days of treatment with cefuroxime axetil. One study showed faropenem medoxomil to be superior to cefuroxime axetil. Overall, the safety profile of faropenem medoxomil is similar to that of most comparators.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9350
Product nameFaropenem daloxate
CAS141702-36-5
Molecular formulaC17H19NO8S
Molecular weight397.3997
Purity>98%
SMILESO=C1N(C(C(OCC(O2)=C(C)OC2=O)=O)=C([C@H]3CCCO3)S4)[C@@]4([H])[C@@]1([H])[C@H](O)C

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Faropenem daloxate (DC9350)

Related research products